ILLUMINA
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and ... prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. David R. Walt, Satnam Alag, Larry Bock, and John Stuelpnagel co-founded Illumina in San Diego, California in 1998.
ILLUMINA
Industry:
Biotechnology Genetics Health Care Medical
Founded:
1998-01-01
Status:
Active
Contact:
858.202.4500
Email Addresses:
[email protected]
Total Funding:
28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Apache
Similar Organizations
Aegis Sciences
A forensic toxicology and health care sciences laboratory.
ArmaGen Technologies
ArmaGen is focused on developing technologies for siRNA delivery across the blood-brain barrier.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Celixir
Celixir is a unique technology platform drives in-house discovery and manufacturing.
Crystalplex
Crystalplex provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets.
Cynvec
Cynvec is a biotechnology company that develops a proprietary oncolytic technology for the treatment of cancer.
Genetic Technologies
Genetic Technologies is a molecular diagnostics company specializing in oncology.
Goodwin Biotechnology, Inc.
Goodwin Biotechnology is a biotechnology company that offers biologics process development and purification bioconjugation services.
Lasergen
Lasergen is a biotechnology company developing and commercializing technologies for genomic applications.
LifeWave
LifeWave focuses on developing non-invasive and sensing technology for prenatal and neonatal monitoring in clinical and remote settings.
Naviscan
Naviscan develops a high-resolution PET scanner that provides unprecedented visualization of small body parts.
NextCare
NextCare offers urgent care and occupational medical services for various illnesses such as cough, diaper rashes, earaches and more.
PolarityTE
PolarityTE is revolutionary platform induces cell and tissue polarity, creating uniquely functional tissue.
Ravgen
Ravgen is a biotechnology company that specializes in non-invasive prenatal diagnostic testing.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-06-28 | IDbyDNA | IDbyDNA acquired by Illumina | N/A |
| 2020-09-21 | Grail | Grail acquired by Illumina | 8 B USD |
| 2020-07-14 | Enancio | Enancio acquired by Illumina | N/A |
| 2020-06-17 | Bluebee | Bluebee acquired by Illumina | N/A |
| 2018-05-15 | Edico Genome | Edico Genome acquired by Illumina | 100 M USD |
| 2016-01-27 | Conexio Genomics | Conexio Genomics acquired by Illumina | N/A |
| 2015-08-04 | GenoLogics | GenoLogics acquired by Illumina | N/A |
| 2013-10-28 | NextBio | NextBio acquired by Illumina | N/A |
| 2013-07-23 | Advanced Liquid Logic | Advanced Liquid Logic acquired by Illumina | 96 M USD |
| 2013-01-08 | Moleculo | Moleculo acquired by Illumina | N/A |
Investors List
CW Group
CW Group investment in Venture Round - Illumina
Venrock
Venrock investment in Venture Round - Illumina
Lombard Odier
Lombard Odier investment in Venture Round - Illumina
Chevron Technology Ventures
Chevron Technology Ventures investment in Venture Round - Illumina
The Dow Chemical Company
The Dow Chemical Company investment in Venture Round - Illumina
Chase Capital Partners
Chase Capital Partners investment in Venture Round - Illumina
ARCH Venture Partners
ARCH Venture Partners investment in Venture Round - Illumina
Tredegar Investments
Tredegar Investments investment in Venture Round - Illumina
State Farm Insurance
State Farm Insurance investment in Venture Round - Illumina
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | Mable (Neurolytic Healthcare) | Illumina investment in Pre Seed Round - Mable (Neurolytic Healthcare) | N/A |
| 2021-09-01 | SomaLogic | Illumina investment in Post-IPO Equity - SomaLogic | 375 M USD |
| 2021-04-01 | Concr | Illumina investment in Seed Round - Concr | 499.84 K GBP |
| 2020-05-28 | Ginkgo Bioworks | Illumina investment in Series F - Ginkgo Bioworks | 70 M USD |
| 2020-05-06 | Grail | Illumina investment in Series D - Grail | 390 M USD |
| 2018-03-01 | Helixis | Illumina investment in Venture Round - Helixis | 200 M USD |
| 2018-03-01 | Helix | Illumina investment in Series B - Helix | 200 M USD |
| 2016-11-15 | Prospect Bio | Illumina investment in Seed Round - Prospect Bio | 2.8 M USD |
| 2016-02-17 | Vitagene | Illumina investment in Seed Round - Vitagene | 2 M USD |
| 2016-01-12 | Grail | Illumina investment in Series A - Grail | 100 M USD |
Newest Events participated
Participated in Rock Health Summit
on 2015-09-29 as exhibitor
Key Employee Changes
More informations about "Illumina" on Search Engine
Management Team - Illumina
At Illumina, our core values stem from innovation, discovery, and collaboration. As an executive team, we strive to deliver leading genomic technologies that enable boundless research discovery and pioneering personalized health.See details»
About Us | A global leader in genomics - Illumina
We are a global genomics and human health leader innovating the future of precision health. We develop DNA sequencing and array-based life sciences technologies to enable boundless research discovery and personalized health.See details»
Illumina, Inc. - Wikipedia
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California, and it serves more than 155 countries. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function.See details»
Org Chart Illumina - The Official Board
The organizational chart of Illumina displays its 85 main executives including Jacob Thaysen, Ankur Dhingra and Joydeep Goswami.See details»
Illumina | LinkedIn
About us. At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even...See details»
Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief ...
SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN ), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has appointed...See details»
Illumina, Inc. - Governance
Illumina, Inc. - Governance. Supporting Investor Confidence. At Illumina, Inc., our Board of Directors and management believe that good corporate governance is an important component in enhancing investor confidence in the …See details»
Illumina CTO: Fueling Innovation, Inventing the Future - WSJ
Feb 4, 2022 Illumina plans to maintain a pipeline of new products and capabilities to meet the evolving needs of its customers—including genomic research centers, pharmaceutical companies, academic...See details»
Illumina's CEO and Executive Team - Team members and org …
The executive team at Illumina has a history of experience in human resources, law, electrical engineering, and computer science.See details»
Illumina, Inc. - Illumina announces CEO transition plan
Jun 11, 2023 Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has accepted the resignation of Francis deSouza as Illumina's Chief Executive Officer and as a Director, effective Sunday, June 11.See details»
Illumina, Inc. - Illumina Announces Corporate Reorganization
SAN DIEGO, Jan 04, 2008 (BUSINESS WIRE) -- Illumina, Inc. (NASDAQ:ILMN) today announced that it hasreorganized its operating structure to further leverage the synergiesbetween its sequencing and genotyping businesses.See details»
Board of Directors - Illumina
Our Board of Directors is a diverse group of leaders who champion scientific innovation. The Board ensures that the company is equipped with the tools that it needs to accelerate the power of genomics.See details»
Illumina | World Economic Forum
Illumina develops, manufactures and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. With rapid advances in technology taking place, it is mission-critical to offer solutions that are innovative, flexible and scalable, with industry-leading support and service.See details»
Illumina - Crunchbase Investor Profile & Investments
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function. These studies will help make the realization of personalized medicine possible.See details»
Illumina | Devex
About. As a startup, Illumina aspired to transform human health. Their initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene...See details»
Illumina | Sequencing and array solutions to fuel genomic …
Feb 13, 2024 Two Industry Leaders on the Growing Complexity of Genomic Cancer Data. Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.See details»
Working at Illumina | Glassdoor
15 Locations. Type: Company - Public (ILMN) Founded in 1998. Revenue: $1 to $5 billion (USD) Biotech & Pharmaceuticals. Competitors: Thermo Fisher Scientific, Roche Create Comparison. Illumina is a global leader in genomics—an industry at the intersection of biology and technology.See details»
Illumina: Business Model, SWOT Analysis, and Competitors 2023
May 2, 2023 What is the mission statement of Illumina? Illumina's Mission Statement: Advancing Human Health by Unlocking the Power of the Genome. Driving Scientific Discoveries. Developing Innovative Solutions. Empowering Individuals with Genetic Information. How does Illumina make money? Revenue Streams. Genomic Sequencing …See details»
Illumina Canada | Devex
Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.See details»
Corporate and Social Responsibility | Illumina CSR Report
Innovating at the intersection of biology, technology, and health, Illumina is advancing genomics for good to create a healthier, more sustainable, and more equitable future for all. We focus these efforts on five priorities: Accelerate access to genomics. Empower our communities. Integrate sustainability. Nurture our people. Operate responsibly.See details»